Clinical Evaluation of Goiter and Risk of Malignancy
DOI:
https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v46i3.1377Keywords:
nodular goiter, thyroid neoplasms, physical examination, risk prediction, editorialAbstract
Based on the study by Daza on predictors of malignancy in goiter, this commentary analyzes the value of the initial clinical history and physical examination. In resource-limited settings, identifying clinical red flags is key to prioritizing timely access to more complex ultrasound and cytological evaluations.
Downloads
References
Daza AB. Factores clínicos y demográficos asociados a carcinoma diferenciado de tiroides en pacientes con bocio de larga data en Bolivia. Rev Hosp Ital B.Aires. 2026;46(3):e0001290.
Bernet VJ, Chindris AM. Update on the evaluation of thyroid nodules. J Nucl Med. 2021;62 Suppl 2:13S-19S. https://doi.org/10.2967/jnumed.120.246025
Luo J, McManus C, Chen H, et al. Are there predictors of malignancy in patients with multinodular goiter? J Surg Res. 2012;174(2):207-10.
Durante C, Hegedüs L, Czarniecka A, et al. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur Thyroid J. 2023;12(5):e230067.
Prete FP, De Luca GM, Sgaramella LI, et al. Prevalence and clinical risk factors of thyroid cancer in retrosternal goiter: a retrospective comparative study with cervical multinodular goiter. J Clin Med. 2025;14(2):489. https://doi.org/10.3390/jcm14020489
Ringel MD, Sosa JA, Baloch Z, et al. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid. 2025;35(8):841-985.
Downloads
Published
Data Availability Statement
No corresponde.Issue
Section
License
Copyright (c) 2026 Marcelo F. Figari
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
